The global contrast media injectors market size was valued at USD 1.03 billion in 2021 and is predicted to reach at USD 1.56 billion by 2030, increasing at a CAGR of 4.72% from 2022 to 2030.
Prior to diagnostic imaging techniques such as CT or MRI scans, the use of contrast media injectors improves the image quality by controlling the amount of contrast material. A variety of features, including preprogramed protocols and safety measures, are included in contrast media injectors in order to prevent the accidental overdose of contrast media. There may be decreased chance of air emboli formation if counter media injectors are employed to prevent incorrect contrast material injection. The contrast of the injectors is much enhanced since they reduce the volume of contrast vision.
Those medical devices that inject radio-opaque contrast material into the body for medical imaging procedures are known as contrast injectors. Contrast injectors have evolved over the years from manual injectors with manifolds with stop-cocks to automated versions that offer more accuracy and advantages. Auto injectors are the name given to these automated versions. To keep pace with today's high-speed medical imaging scanners, auto injectors can manage the amount of contrast media injected, the rate at which it is absorbed into the patient's body, and notify the physician to potential hazards, example air embolisms and perhaps even extravasations.
The number of persons affected by cancer has risen dramatically during the past few decades. Additionally, cardiovascular disease and strokes account for the most deaths globally. The World Health Organization (WHO) estimates that cardiovascular disease (CVD) is the leading cause of death worldwide. Nearly 23.6 million people are expected to die from cardiovascular disease by 2030, according to the World Health Organization's (WHO) projections for 2015.
At the moment of diagnostic imaging, contrast media injectors inject radio-opaque contrast material into the body of the patient to increase image quality and safety. Contrast media injectors are expected to benefit from an increase in the number of cancer and cardiovascular disease patients, which will lead to a rise in demand for upgraded healthcare facilities and advanced diagnostic imaging methods, which will consequently drive the market for contrast media injectors.
The market's growth rate is expected to increase as a result of the federal government's increased support. Increasing use of diagnostic imaging in the fields of radiology as well as image-guided minimally invasive surgery means that governments are giving enough financing for diagnostic imaging services, and this money is growing dramatically each year.
The market for medical instruments and devices will continue to rise as more money is spent on research and development in both developed and emerging nations. In 2021, the World Health Organization predicted that cardiovascular disease would be the leading cause of death in the world.
Personal disposable income, rising demand for minimally invasive surgeries, and increased investment in the development of innovative medical technologies are all factors that contribute to the market's rapid expansion.
Market growth is projected to be hampered by the high cost of contrast media injectors over the forecast period. The cost of consumables is also recurring because the same syringe & tube cannot be used twice, which is another factor that will limit market growth in the future. Tubes and syringes can cost as much as US$ 350-500 per, limiting their use by healthcare practitioners.
In addition, a scarcity of knowledge is anticipated to have a negative impact on the market over the period under consideration, too. It is also possible to develop air embolisms during the injection of contrast media, which could lead to serious consequences such as heart failure or respiratory failure. Contrast media injectors market revenue growth is expected to be stifled by the negative side effects of injections.
LCD screens have been added to contrast media injectors to monitor patient status. With the implementation of cutting-edge technology, the future looks bright for business expansion. An injector system for computed tomography has been developed by Bracco.
Dual syringe operation, auto initialization of syringes for filling, and protocol fill automatically fill syringes to volumes based on the set protocol are all features of this workflow efficiency tool.
Data from injector systems may now be accessed in real time thanks to new software. In the approaching years, the market is likely to be fueled by the collaborations amongst the industry's leaders. OptiSync is a new data management solution from Mallinckrodt. An improved CT imaging process that utilizes contrast media results in this type of radiological data analysis.
The Global Contrast Media Injectors Market is divided into different segments according to the Product, Type, Application, End Use, and Region (Geography).
By Product, the Global Contrast Media Injectors Market is segmented into Injector Systems and Consumables. Injector systems dominated the market in 2021, bringing in more than 60% of total revenue. CT, MRI, and angiography imaging treatments all use contrast agents that are injected into the patients' bloodstreams in order to enhance the contrast of fluids or structures within the body. Contrast media injector systems include, for example, those used in CT scans, MRI scans, and cardiovascular/angiography scans. In terms of contrast media injectors, the CT injector systems category accounts for the largest share of the overall market. This is because of its broad usage in the diagnosis and treatment of vascular disease, cancer, and orthopedic injuries and diseases.
During the projected period, the consumables segment is predicted to have the greatest CAGR of 5.69%. This segment's rapid expansion might be attributed to the increased need for diagnostic consumables to ensure safety and hygienic conditions. Consumable purchases for radiology, interventional cardiology and interventional radiology are likely to raise the segment's share as well, as are recurring purchases of these items.
By Type, the Global Contrast Media Injectors Market is segmented into Single Head Injectors, Dual-Head Injectors, and Syringe less Injectors. In 2021, single-head injectors dominated the market, bringing in more than 45% of the total revenue. Angiography, computed tomography, and magnetic resonance imaging (MRI) all use single-head injectors. Contrast material can be delivered using only one syringe using these injectors. Angiography uses single-head injectors, while CT uses dual-head injectors, which have two syringes.
This market is predicted to grow at the fastest rate, with a compound annual growth rate (CAGR) of 5.98%. To save waste, syringe-free power injectors have recently become popular. As syringe-free injectors become more widely available, several large firms are working to bring them to market.
By Application, the Global Contrast Media Injectors Market is segmented into Radiology, Interventional Cardiology, and Interventional Radiology. In 2021, radiology accounted for more than 45% of the global revenue, making it the dominant market segment. Using non-invasive imaging modalities such as CT and MRI scans, radiologists are able to provide incredibly detailed images in their work. Cross-sectional images of the body can be constructed using CT scans, which employ an X-ray machine for cross-sectional images of the body, while MRI uses magnetic fields to make images inside an individual's body.
CAGR of 5.84% for the interventional cardiology segment is expected throughout the predicted period. Stroke, heart attack, arrhythmia, and heart valve abnormalities are among the more common cardiac ailments, and this is projected to be a driving factor in the segment's growth.
By End Use, the Global Contrast Media Injectors Market is segmented into Hospitals, Diagnostics Centres, and Ambulatory Surgery Centres. Over 70% of the global income in 2021 came from the hospital segment, due to an increase in admissions of patients with neurological disorders, cardiovascular diseases, and cancer. Contrast media injectors are mostly used in hospitals because of their vast range of uses in radiology, interventional radiology, and interventional cardiology.
In 2021, diagnostics centres accounted for more than 25% of global revenue, placing them second only to hospitals as the largest revenue generators. Small and mid-sized hospitals' lack of diagnostic imaging modalities, as well as the rising demand for diagnostic imaging and early diagnosis, are two major factors driving the growth of diagnostic imaging centres. People's awareness of chronic illnesses is likely to increase demand for angiography operations, which can be used for diagnosis, treatment planning, and prevention.
By Region or Geography, the Global Contrast Media Injectors Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America held a commanding position in the market, with a share of worldwide revenue of more than 40%. A rise in the number of inpatient examinations is projected as a result of the region's well-established healthcare facilities, easy access to new technologies, and high demand for diagnostic procedures. Contrast media injectors in the Asia Pacific region are expected to rise at a 5.57% annual rate. Asia Pacific's contrast media injectors market is dominated by Japan, China, and India.
The Global Contrast Media Injectors Market is segmented by geography into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
In 2021, North America held a dominant position in the market, accounting for more than 40% of the total revenue generated worldwide. It is anticipated that the presence of numerous well-established healthcare facilities, the simple availability of cutting-edge technologies, and the high demand for diagnostic procedures in this region will lead to an increase in the number of inpatient examinations, which in turn is anticipated to boost the growth of the market.
In addition, nations like the United States and Canada have experienced a rise in the number of people admitted to hospitals over the course of the past few years. This trend can be attributed to the prevalence of chronic medical conditions and fatal injuries. According to the Centres for Disease Control and Prevention (CDC), the leading cause of disability and mortality is chronic disease. Six out of ten adults in the United States are living with at least one chronic condition, and four out of ten adults have two or more chronic diseases. In addition, the Canadian Institute of Health (CIH) found that during the years 2016 and 2017, there were over 17,655 people admitted to hospitals due to injuries sustained while participating in sports.
It is anticipated that the Asia Pacific contrast media injectors market will expand at a rate of 5.57%. Japan, China, and India are the three countries that have made the most contributions to the contrast media injectors market in Asia Pacific. The market in this region is being driven higher by a number of important factors, including rapidly developing economies, an increasing awareness about healthcare, and an ageing population.
It is anticipated that the demand for contrast media injectors will increase as a result of several factors. These factors include the rising incidence of chronic diseases such as neurological disorders and the growing number of elderly people. In addition, there is a strong correlation between ageing and neurological diseases, which typically manifest themselves in people aged 60 and older. Because of this, there is a high demand for innovative surgical treatment solutions for these diseases, which is anticipated to propel the demand for innovative contrast media injectors.
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|